Imatinib administration in two patients with liver metastases from GIST and severe jaundice

Por De Pas, T, Danesi, R, Catania, C, Curigliano, G, de Braud, F
Publicado em 2003

Detection of the common acute lymphoblastic leukaemia antigen (CALLA) on B cells from human fetal tissues. A multiple phenotypic characterization.

Por Delia, D, Cattoretti, G, Bonati, A, Villa, S, De Braud, F, Buscaglia, M
Publicado em 1985

Immune cell engagers in solid tumors: promises and challenges of the next generation immunotherapy

Por Fucà, G., Spagnoletti, A., Ambrosini, M., de Braud, F., Di Nicola, M.
Publicado no ESMO Open (2021)

Peptide receptor radiotherapy: a new option for the management of aggressive fibromatosis on behalf of the Italian Sarcoma Group

Por De Pas, T, Bodei, L, Pelosi, G, de Braud, F, Villa, G, Capanna, R, Paganelli, G
Publicado em 2003

Neuroendocrine tumour arising inside a retro-rectal tailgut cyst: report of two cases and a review of the literature

Por Spada, F, Pelosi, G, Squadroni, M, Lorizzo, K, Farris, A, de Braud, F, Fazio, N
Publicado em 2011

Prognostic factors for survival in patients with metastatic renal cell carcinoma treated with targeted therapies

Por Procopio, G, Verzoni, E, Iacovelli, R, Biasoni, D, Testa, I, Porcu, L, De Braud, F
Publicado em 2012

Targeted treatments in advanced renal cell carcinoma: focus on axitinib

Por Verzoni E, Grassi P, Testa I, Iacovelli R, Biondani P, Garanzini E, De Braud F, Procopio G
Publicado em 2014-03-01

Gemcitabine-induced progressive and sustained tumour response in a patient with multi-drug resistant uterine leiomyosarcoma

Por De Pas, T, Spitaleri, G, Vigna, PD, Toffalorio, F, Curigliano, G, Gambino, A, Boselli, S, Catania, C, de Braud, F
Publicado em 2008

QTc prolongation assessment in anticancer drug development: clinical and methodological issues

Por Curigliano, G, Spitaleri, G, de Braud, F, Cardinale, D, Cipolla, C, Civelli, M, Colombo, N, Colombo, A, Locatelli, M, Goldhirsch, A
Publicado em 2009

Lessons from the ‘Iressa’ Expanded Access Programme: gefitinib in special non-small-cell lung cancer patient populations

Por Stahel, R, Rossi, A, Petruzelka, L, Kosimidis, P, de Braud, F, Bernardo, M M, Souquet, P-J, Parra, H Soto, Gridelli, C
Publicado em 2003

1702P COVID-19 risk for patients undergoing anticancer treatment at the outpatient clinic of the National Cancer Institute of Milan: The COVINT study

Por Nichetti, F., Bini, M., Dotti, K.F., Ottini, A., Ambrosini, M., Rametta, A., Leporati, R., Ferrari, L., De Braud, F.G.M.
Publicado no Ann Oncol (2020)

Prognostic value of clinicopathological parameters in head and neck squamous cell carcinoma: a prospective analysis.

Por Janot, F., Klijanienko, J., Russo, A., Mamet, J. P., de Braud, F., El-Naggar, A. K., Pignon, J. P., Luboinski, B., Cvitkovic, E.
Publicado em 1996

Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma

Por Santoro, A, Pressiani, T, Citterio, G, Rossoni, G, Donadoni, G, Pozzi, F, Rimassa, L, Personeni, N, Bozzarelli, S, Rossoni, G, Colombi, S, De Braud, F G, Caligaris-Cappio, F, Lambiase, A, Bordignon, C
Publicado em 2010

Vatalanib for metastatic gastrointestinal stromal tumour (GIST) resistant to imatinib: final results of a phase II study

Por Joensuu, H, De Braud, F, Grignagni, G, De Pas, T, Spitalieri, G, Coco, P, Spreafico, C, Boselli, S, Toffalorio, F, Bono, P, Jalava, T, Kappeler, C, Aglietta, M, Laurent, D, Casali, P G
Publicado em 2011

Institutional guidelines and ongoing studies in management of liver tumours: the experience of the European Institute of Oncology

Por Biffi, R, Orsi, F, Zampino, MG, Chiappa, A, Fazio, N, De Braud, F, Bonomo, G, Monfardini, L, Vigna, PD, Luca, F, Bodei, L, Bartolomei, M, Catalano, G, Leonardi, MC, Ferrari, M, Andreoni, B, Goldhirsch, A, Paganelli, G, Orecchia, R
Publicado em 2008

A phase I study to determine the safety, pharmacokinetics and pharmacodynamics of a dual VEGFR and FGFR inhibitor, brivanib, in patients with advanced or metastatic solid tumors

Por Jonker, D. J., Rosen, L. S., Sawyer, M. B., de Braud, F., Wilding, G., Sweeney, C. J., Jayson, G. C., McArthur, G. A., Rustin, G., Goss, G., Kantor, J., Velasquez, L., Syed, S., Mokliatchouk, O., Feltquate, D. M., Kollia, G., Nuyten, D. S. A., Galbraith, S.
Publicado em 2011

Analysis of plasma cytokines and angiogenic factors in patients with pretreated urothelial cancer receiving Pazopanib: the role of circulating interleukin-8 to enhance the prognost...

Por Necchi, A, Pennati, M, Zaffaroni, N, Landoni, E, Giannatempo, P, Raggi, D, Schwartz, L H, Morosi, C, Crippa, F, Farè, E, Nicolai, N, Lanocita, R, Sava, T, Sacco, C, Messina, C, Ortega, C, De Braud, F G, Salvioni, R, Daidone, M G, Gianni, A M, Mariani, L
Publicado em 2014

Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study

Por Long, G. V., Flaherty, K. T., Stroyakovskiy, D., Gogas, H., Levchenko, E., de Braud, F., Larkin, J., Garbe, C., Jouary, T., Hauschild, A., Chiarion-Sileni, V., Lebbe, C., Mandalà, M., Millward, M., Arance, A., Bondarenko, I., Haanen, J. B. A. G., Hansson, J., Utikal, J., Ferraresi, V., Mohr, P., Probachai, V., Schadendorf, D., Nathan, P., Robert, C., Ribas, A., Davies, M. A., Lane, S. R., Legos, J. J., Mookerjee, B., Grob, J.-J.
Publicado no Ann Oncol (2017)

Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study

Por Long, G V, Flaherty, K T, Stroyakovskiy, D, Gogas, H, Levchenko, E, de Braud, F, Larkin, J, Garbe, C, Jouary, T, Hauschild, A, Chiarion-Sileni, V, Lebbe, C, Mandalá, M, Millward, M, Arance, A, Bondarenko, I, Haanen, J B A G, Hansson, J, Utikal, J, Ferraresi, V, Mohr, P, Probachai, V, Schadendorf, D, Nathan, P, Robert, C, Ribas, A, Davies, M A, Lane, S R, Legos, J J, Mookerjee, B, Grob, J -J
Publicado no Ann Oncol (2019)

Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort

Por Peretti, U., Cavaliere, A., Niger, M., Tortora, G., Di Marco, M.C., Rodriquenz, M.G., Centonze, F., Rapposelli, I.G., Giordano, G., De Vita, F., Stuppia, L., Avallone, A., Ratti, M., Paratore, C., Forti, L.G., Orsi, G., Valente, M.M., Gaule, M., Macchini, M., Carrera, P., Calzavara, S., Simbolo, M., Melisi, D., De Braud, F., Salvatore, L., De Lorenzo, S., Chiarazzo, C., Falconi, M., Cascinu, S., Milella, M., Reni, M.
Publicado no ESMO Open (2021)